Literature DB >> 10404841

Prop-1 gene expression in human pituitary tumors.

S Nakamura1, A Ohtsuru, N Takamura, G Kitange, Y Tokunaga, A Yasunaga, S Shibata, S Yamashita.   

Abstract

A novel type of pituitary-specific transcription factor, Prophet of Pit-1 (Prop-1) gene (PROP1), expresses in just early embryonic stage in mouse and closely related as a causative gene in combined pituitary hormone deficiency. We studied PROP1 expression to further clarify its correlation with tumorigenesis and biological behavior in human pituitary adenomas. Eighteen pituitary adenomas and three normal pituitary glands were examined for the expression of PROP1 and POU1F1 by using RT-PCR Pituitary adenomas were diagnosed as non-functioning adenomas (n = 11), prolactinomas (n=5), GH-producing adenoma (n = 1) and ACTH-producing adenoma (n = 1). One of non-functioning adenomas was pituitary carcinoma with cerebellar metastasis and CSF dissemination. Our results demonstrated PROP1 expression in all pituitary tumors examined, in contrast, POU1F1 was detected in 14 of pituitary tumors. PROP1 was also expressed in normal pituitary gland, however, it was not in normal brain tissue, glioblastomas (cell lines and tumor tissues) and meningioma. Our data indicated that PROP1 expression was observed constantly both in the pituitary tumors and normal human adult pituitary tissues, suggesting that PROP1 is an essential transcriptional factor for pituitary specific gene expression in human. Therefore, detection of PROP1 might be a useful indicator for differentiating pituitary adenomas, regardless of their hormonal phenotypes, from other brain tumors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10404841     DOI: 10.1210/jcem.84.7.5974

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Case seminar: a young female with acute hyponatremia and a sellar mass.

Authors:  Sandra Pekic; Mirjana Doknic; Dragana Miljic; Alexandru Saveanu; Rachel Reynaud; Anne Barlier; Thierry Brue; Vera Popovic
Journal:  Endocrine       Date:  2011-08-24       Impact factor: 3.633

2.  Immunonegative "null cell" adenomas and gonadotropin (Gn) subunit (SUs) immunopositive adenomas share frequent expression of multiple transcription factors.

Authors:  Yudo Ishii; Masanori Suzuki; Susumu Takekoshi; Noboru Egashira; Michio Yamazaki; Shunsuke Miyai; Naoko Sanno; Akira Teramoto; Robert Yoshiyuki Osamura
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

Review 3.  Genesis of pituitary adenomas: state of the art.

Authors:  G Faglia; A Spada
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

Review 4.  Mechanisms for pituitary tumorigenesis: the plastic pituitary.

Authors:  Shlomo Melmed
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

5.  Human pituitary tumours express the bHLH transcription factors NeuroD1 and ASH1.

Authors:  E Ferretti; D Di Stefano; F Zazzeroni; R Gallo; A Fratticci; R Carfagnini; S Angiulli; A Santoro; G Minniti; G Tamburrano; E Alesse; G Cantore; A Gulino; M L Jaffrain-Rea
Journal:  J Endocrinol Invest       Date:  2003-10       Impact factor: 4.256

6.  Adrenocorticotrope deficiency with clinical evidence for late onset in combined pituitary hormone deficiency caused by a homozygous 301-302delAG mutation of the PROP1 gene.

Authors:  C Lamesch; S Neumann; R Pfäffle; W Kiess; R Paschke
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

7.  PROP1 overexpression in corticotrophinomas: evidence for the role of PROP1 in the maintenance of cells committed to corticotrophic differentiation.

Authors:  Ricardo V Araujo; Claudia V Chang; Valter A S Cescato; Maria Candida B V Fragoso; Marcello D Bronstein; Berenice B Mendonca; Ivo J P Arnhold; Luciani R S Carvalho
Journal:  Clinics (Sao Paulo)       Date:  2013-06       Impact factor: 2.365

8.  Comparative genomics reveals functional transcriptional control sequences in the Prop1 gene.

Authors:  Robert D Ward; Shannon W Davis; Minchul Cho; Constance Esposito; Robert H Lyons; Jan-Fang Cheng; Edward M Rubin; Simon J Rhodes; Lori T Raetzman; Timothy P L Smith; Sally A Camper
Journal:  Mamm Genome       Date:  2007-06-08       Impact factor: 2.957

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.